2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
November 29, 2023
Video
The expert panel reviews the results from the TROPION-Lung01 study and discusses how the data can inform treatment decisions for patients with previously treated NSCLC.
November 28, 2023
Article
Benjamin Philip Levy, MD, discusses the current landscape of emerging antibody-drug conjugates (ADCs) and their early activity in advanced lung cancer, the potential utility of oncogene-directed ADCs for patients with driver mutations, and more.
November 24, 2023
Video
Experts in breast, lung, and gastric malignancies provide insights on multidisciplinary care in oncology and educating community specialists.
November 24, 2023
Video
Medical oncologists discuss prospects and challenges in the breast and lung cancer treatment landscapes.
November 22, 2023
Video
Solange Peters, MD, PhD, reviews key data from TROPION-Lung01 investigating datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced non–small cell lung cancer.
November 22, 2023
Video
Clinical insights on how the level of PD-L1 expression informs treatment decisions for patients with non–small cell lung cancer.
November 17, 2023
Video
Specialists in gastric cancer look to the future treatment landscape and review ongoing research in the disease space.
November 17, 2023
Video
Clinical insights on best practices for treating patients with TROP2-targeted therapy.
November 15, 2023
Video
Experts on non–small cell lung cancer discuss the role of CTLA-4 inhibitors in the NSCLC treatment landscape.
November 15, 2023
Video
A panel of thoracic medical oncologists provide an overview of first-line treatment strategies for advanced non–small cell lung cancer (NSCLC).
November 14, 2023
Video
Benjamin Philip Levy, MD, discusses the ongoing development of the TROP-2 directed antibody-drug conjugates sacituzumab govitecan-hziy and datopotamab deruxtecan in non–small cell lung cancer, their different toxicity profiles, as well as the potential categorization of emerging ADCs as onco-directed therapies in this patient population.
November 11, 2023
Video
Benjamin Philip Levy, MD, discusses antibody-drug conjugates under investigation in patients with non–small cell lung cancer.
November 10, 2023
Video
The expert panel discusses TROP2 as a target for patients with cancer who are receiving antibody-drug conjugates.
November 10, 2023
Video
A review of antibody-drug conjugates approved for treatment of patients with breast, lung, or gastrointestinal cancers.
November 09, 2023
Article
The mitigation and management of toxicities is a key component of treating patients with biliary tract cancers with targeted therapies.
November 03, 2023
Video
Insights on managing antibody-drug conjugate toxicities for patients with gastric cancer.
November 03, 2023
Video
A GI medical oncologist discusses the role of trastuzumab deruxtecan in the gastric cancer treatment space.
October 31, 2023
Video
Expert oncologist Benjamin Levy, MD, shares data from the LIBRETTO-431 trial comparing selpercatinib to chemotherapy plus pembrolizumab in RET fusion-positive NSCLC following ESMO 2023.
October 27, 2023
Video
A nurse practitioner provides insights on toxicity management strategies for patients with lung cancer who are receiving antibody-drug conjugates.
October 27, 2023
Video
A medical oncologist reviews the antibody-drug conjugate landscape in lung cancer.